New study identifies top-performing point-of-care COVID-19 tests

Researchers at NSF International and Novateur Ventures screen rapid-detection COVID-19 tests for clinical sensitivity/specificity, limit of detection and time to results


After screening more than 1,100 independently assessed, point-of-care COVID-19 tests, researchers at NSF International and Novateur Ventures have identified 5 direct (antigen/RNA) tests for detection of acute infection and 6 indirect (antibody) tests for detection of prior infection that meet the recently published World Health Organization (WHO) “desirable” Target Product Profile (TPP) criteria. The researchers hope their work will help communities and healthcare systems make more informed decisions when choosing rapid, point-of-care COVID-19 tests.

Read Article Here